9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen

Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen

Estimated reading time: < 1 min

Condition: Non-small Cell Lung Cancer

Estimated Enrollment: 31

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Completed

Study Results: Has Results

Outcome Measures: Overview of Adverse Events,  Number of Participants With Common Toxicity Criteria – National Cancer Institute Grade 3 and Grade 4 Toxicities,  Pemetrexed Population Pharmacokinetics (PK): Clearance, Pemetrexed Population Pharmacokinetics: Volume of Distribution

Interventions: pemetrexed,

Phase:

Study Type: Interventional

Study Design: Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: None (Open Label),Primary Purpose: Treatment

Primary Completion Date: March 2009

Completion Date: March 2009

Last  Posted Date: July 9, 2010

Location: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon – Fri from 9 AM to 5 PM Eastern Time (UTC/GMT – 5 hours, EST), or speak with your personal physician., Kobenhavn, Denmark

Website Link: https://ClinicalTrials.gov/show/NCT00316225

Was this article helpful?
Dislike 0